Once a poorly defined pathologic oddity, in recent years, gastrointestinal stromal tumor
(GIST) has emerged as a distinct oncogenetic entity that is now center stage in clinical trials …

The NCCN Soft Tissue Sarcoma Guidelines include a subsection about treatment
recommendations for gastrointestinal stromal tumors (GISTs). The standard of practice …

Background Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal
tumors of the gastrointestinal tract. Neoplastic GIST cells seem to arise from a common …

Objective To analyze the outcome of 200 patients with gastrointestinal stromal tumor (GIST)
who were treated at a single institution and followed up prospectively. Summary Background …

Background Gastrointestinal stromal tumour is the most common sarcoma of the intestinal
tract. Imatinib mesylate is a small molecule that inhibits activation of the KIT and platelet …

Gastrointestinal (GI) stromal tumors (GISTs), the specific KIT-or PDFGRA-signaling driven
mesenchymal tumors, are the most common mesenchymal tumors of the GI tract. In this …

Sarcomas are a heterogeneous group of rare tumors that arise predominantly from the
embryonic mesoderm. They present most commonly as an asymptomatic mass originating in …

Background Adjuvant imatinib mesylate prolongs recurrence-free survival (RFS) after
resection of localised primary gastrointestinal stromal tumours (GIST). We aimed to develop …

OJECTIVES The epidemiology of gastrointestinal stromal tumor has not been well
examined, and prior studies often provide conflicting results. We conducted the first …

Gastrointestinal stromal tumours are the most common mesenchymal neoplasm of the
gastrointestinal tract and are highly resistant to conventional chemotherapy and …